A New Edge Data Center Bet in Nigeria
A new player, Fringe Infrastructure, has entered Nigeria’s data center market with a launch in Lagos. The company is taking a power-first, edge-focused approach with ambitious expansion plans.
A new player, Fringe Infrastructure, has entered Nigeria’s data center market with a launch in Lagos. The company is taking a power-first, edge-focused approach with ambitious expansion plans.
Realme is reportedly returning to its roots as a sub-brand of Oppo. The move aims to strengthen internal collaboration and resource management across the BBK-derived brands.
Elon Musk’s artificial intelligence company, xAI, has raised a massive $20 billion in a Series E round. The funding news arrives amid international investigations into its Grok chatbot for easily creating harmful deepfake imagery.
Vitrealab has closed an $11 million Series A to industrialize its Quantum Light Chip for AR glasses. The tech promises smaller, brighter, more efficient displays. But the AR hardware graveyard is full of good ideas.
The cost for Taiwanese investors to hedge against a weaker US dollar has slumped to its lowest since 2016. This dramatic shift follows an accounting rule overhaul that prompted local life insurers to unwind massive hedging positions.
Barry Diller, the architect behind Fox and IAC, argues that the best leaders figure it out as they go. His key tool? Fostering passionate “creative conflict” while ruthlessly banning cynicism from the room.
The investment bank has submitted applications to the SEC for the new funds. This follows the massive success of spot Bitcoin ETFs, which now hold over $120 billion in assets.
Brazilian mobile banking app PicPay has filed for a U.S. initial public offering, aiming to raise around $500 million. The company, backed by the Batista family, posted a 79% jump in profit for the first nine months of 2025.
A new device shown at CES 2026 could let people with food allergies test their meals at the table. The Allergen Alert mini lab is a portable, battery-operated gadget that provides near-instant results for gluten and common allergens.
The legendary fund that seeded D.E. Shaw is trying to reinvent itself again. After a turbulent 18 months, new CEO Ravi Singh is pushing a diversified, talent-friendly strategy. But can it compete with giants like Citadel and Millennium?